CN Patent

CN105456222B — 马来酸阿法替尼片及其制备方法

Assigned to HENAN RUNHONG PHARMACEUTICAL CO Ltd · Expires 2019-03-26 · 7y expired

What this patent protects

本发明公开了一种马来酸阿法替尼片及其制备方法,属于医药技术领域。马来酸阿法替尼片由片芯和包裹在片芯外的薄膜包衣组成,片芯由以下质量份数的原料制成:马来酸阿法替尼57~61份,无水乳糖170~180份,微晶纤维素60~70份,交联聚维酮30~36份,二氧化硅1.5~2.5份,硬脂酸镁3~5份,其中无水乳糖、微晶纤维素为填充剂,交联聚维酮为崩解剂,二氧化硅为助流剂,硬脂酸镁为润滑剂;薄膜包衣采用以下质量份数的原料:薄膜包衣预混剂13.5份,水169.1份,包衣增重2%~4%。该片剂具有速释特性,溶出15min>95%,且质量稳定。

USPTO Abstract

本发明公开了一种马来酸阿法替尼片及其制备方法,属于医药技术领域。马来酸阿法替尼片由片芯和包裹在片芯外的薄膜包衣组成,片芯由以下质量份数的原料制成:马来酸阿法替尼57~61份,无水乳糖170~180份,微晶纤维素60~70份,交联聚维酮30~36份,二氧化硅1.5~2.5份,硬脂酸镁3~5份,其中无水乳糖、微晶纤维素为填充剂,交联聚维酮为崩解剂,二氧化硅为助流剂,硬脂酸镁为润滑剂;薄膜包衣采用以下质量份数的原料:薄膜包衣预混剂13.5份,水169.1份,包衣增重2%~4%。该片剂具有速释特性,溶出15min>95%,且质量稳定。

Drugs covered by this patent

Patent Metadata

Patent number
CN105456222B
Jurisdiction
CN
Classification
Expires
2019-03-26
Drug substance claim
No
Drug product claim
No
Assignee
HENAN RUNHONG PHARMACEUTICAL CO Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.